HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.

AbstractRATIONALE:
Studies with genetically engineered mice showed that decreased expression of the transmembrane peptidase neprilysin (NEP) increases susceptibility to hypoxic pulmonary vascular remodeling and hypertension; in hypoxic wild-type mice, expression is decreased early in distal pulmonary arteries, where prominent vascular remodeling occurs. Therefore, in humans with smoke- and hypoxia-induced vascular remodeling, as in chronic obstructive pulmonary disease (COPD), pulmonary activity/expression of NEP may likewise be decreased.
OBJECTIVES:
To test whether NEP activity and expression are reduced in COPD lungs and pulmonary arterial smooth muscle cells (SMCs) exposed to cigarette smoke extract or hypoxia and begin to investigate mechanisms involved.
METHODS:
Control and advanced COPD lung lysates (n = 13-14) were analyzed for NEP activity and protein and mRNA expression. As a control, dipeptidyl peptidase IV activity was analyzed. Lung sections were assessed for vascular remodeling and oxidant damage. Human pulmonary arterial SMCs were exposed to cigarette smoke extract, hypoxia, or H₂O₂, and incubated with antioxidants or lysosomal/proteasomal inhibitors.
MEASUREMENTS AND MAIN RESULTS:
COPD lungs demonstrated areas of vascular rarification, distal muscularization, and variable intimal and prominent medial/adventitial thickening. NEP activity was reduced by 76%; NEP protein expression was decreased in alveolar walls and distal vessels; mRNA expression was also decreased. In SMCs exposed to cigarette smoke extract, hypoxia, and H₂O₂, NEP activity and expression were also reduced. Reactive oxygen species inactivated NEP activity; NEP protein degradation appeared to be substantially induced.
CONCLUSIONS:
Mechanisms responsible for reduced NEP activity and protein expression include oxidative reactions and protein degradation. Maintaining or increasing lung NEP may protect against pulmonary vascular remodeling in response to chronic smoke and hypoxia.
AuthorsMarilee J Wick, Erica J Buesing, Carol A Wehling, Zoe L Loomis, Carlyne D Cool, Martin R Zamora, York E Miller, Sean P Colgan, Louis B Hersh, Norbert F Voelkel, Edward C Dempsey
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 183 Issue 3 Pg. 330-40 (Feb 01 2011) ISSN: 1535-4970 [Electronic] United States
PMID20813891 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Neprilysin
Topics
  • Adolescent
  • Aged
  • Airway Remodeling (physiology)
  • Blotting, Western
  • Case-Control Studies
  • Female
  • Humans
  • Lung (blood supply, chemistry, pathology)
  • Male
  • Middle Aged
  • Neprilysin (analysis, physiology)
  • Pulmonary Alveoli (pathology)
  • Pulmonary Artery (pathology)
  • Pulmonary Disease, Chronic Obstructive (pathology, physiopathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: